Search

everythinglearnresearchcommunity

for

Search:↓

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

The study found no significant link between the symptoms, tissue analysis, and immunofluorescence results in scarring hair loss conditions.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

A young woman with a rare skin cancer was diagnosed late because her symptoms were unusual for the disease.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

Sudden hair whitening may be linked to immune system activity.

Plaque-type herpetic folliculitis affects eccrine glands.

Human melanocytes have unique traits that affect melanoma development and prognosis.

Keratinocyte cytokines and genetic variations influence the development of moles and skin pigmentation.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Kaposi's sarcoma lesions might originate from benign tissue changes.

Early treatment of superficial fungal infections in immunocompromised patients is crucial.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Upadacitinib improved multiple immune-related conditions in one patient.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Melanocytes are important for normal body functions and have potential uses in regenerative medicine and disease treatment.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

A rare type of skin lymphoma was identified, affecting hair follicles and sweat glands.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

The treatment was effective for advanced non-Hodgkin's lymphomas.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

The postnatal thymus has cells like mesenchymal stem cells that can become different cell types and help maintain thymus structure.

Higher levels of certain immune cells in hair follicles may contribute to alopecia areata.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.